CAS
BLUE

Coppell Advisory Solutions’s bluebird bio BLUE Stock Holding History

Coppell Advisory Solutions’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-101
Closed -$28.5K – 1748
2023
Q3 		$28.5K Buy
101
+33
+49% +$2.32K 0.01% 438
2023
Q2 		$20.8K Buy
+68
New +$4.97K 0.01% 551
2023
Q1 		– Sell
-34
Closed -$9.51K – 295
2022
Q4 		$9.51K Buy
+34
New +$4.79K ﹤0.01% 622

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Coppell Advisory Solutions's BLUE Position: Q4 2023 in Review

Coppell Advisory Solutions sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 101 shares — an estimated $28.5K sold.

Coppell Advisory Solutions first reported a position in BLUE in Q4 2022 and held it in 3 quarters. The position peaked at $28.5K in Q3 2023. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Coppell Advisory Solutions reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Coppell Advisory Solutions sold 101 bluebird bio shares in Q4 2023, an estimated $28.5K.
  • Coppell Advisory Solutions first reported a position in bluebird bio in Q4 2022 and held it in 3 quarters.
  • Coppell Advisory Solutions's bluebird bio position peaked at $28.5K in Q3 2023.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Coppell Advisory Solutions's 13F filing for Q4 2023, filed 14 Feb 2024.